Drug Profile
Calcitonin inhalation - Inhale Therapeutic Systems
Alternative Names: Calcitonin aerosol - Inhale Therapeutic Systems; Salcatonin aerosol - Inhale Therapeutic Systems; Salcatonin inhalation - Inhale Therapeutic SystemsLatest Information Update: 27 Nov 2006
Price :
$50
*
At a glance
- Originator Nektar Therapeutics
- Class
- Mechanism of Action Calcitonin stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Bone disorders; Hypercalcaemia; Osteitis deformans; Postmenopausal osteoporosis
Most Recent Events
- 10 Nov 2000 No-Development-Reported for Bone disorders in United Kingdom (Inhalation)
- 10 Nov 2000 No-Development-Reported for Hypercalcaemia in United Kingdom (Inhalation)
- 10 Nov 2000 No-Development-Reported for Osteitis deformans in United Kingdom (Inhalation)